Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
Saved in:
| Title: | Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection. |
|---|---|
| Authors: | Nations KR; Merck Sharp Dohme Corp., Whitehouse Station, NJ, USA., Bursi R, Dogterom P, Ereshefsky L, Gertsik L, Mant T, Schipper J |
| Source: | Drugs in R&D [Drugs R D] 2012 Sep 01; Vol. 12 (3), pp. 127-39. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 22852579 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nations+KR%22">Nations KR</searchLink>; Merck Sharp Dohme Corp., Whitehouse Station, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bursi+R%22">Bursi R</searchLink><br /><searchLink fieldCode="AU" term="%22Dogterom+P%22">Dogterom P</searchLink><br /><searchLink fieldCode="AU" term="%22Ereshefsky+L%22">Ereshefsky L</searchLink><br /><searchLink fieldCode="AU" term="%22Gertsik+L%22">Gertsik L</searchLink><br /><searchLink fieldCode="AU" term="%22Mant+T%22">Mant T</searchLink><br /><searchLink fieldCode="AU" term="%22Schipper+J%22">Schipper J</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883647%22">Drugs in R&D</searchLink> [Drugs R D] 2012 Sep 01; Vol. 12 (3), pp. 127-39. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100883647 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-6901 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211745886%22">11745886 </searchLink><i>NLM ISO Abbreviation: </i>Drugs R D <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22852579 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2165/11634360-000000000-00000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127 Titles: – TitleFull: Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nations KR – PersonEntity: Name: NameFull: Bursi R – PersonEntity: Name: NameFull: Dogterom P – PersonEntity: Name: NameFull: Ereshefsky L – PersonEntity: Name: NameFull: Gertsik L – PersonEntity: Name: NameFull: Mant T – PersonEntity: Name: NameFull: Schipper J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2012 Sep 01 Type: published Y: 2012 Identifiers: – Type: issn-electronic Value: 1179-6901 Numbering: – Type: volume Value: 12 – Type: issue Value: 3 Titles: – TitleFull: Drugs in R&D Type: main |
| ResultId | 1 |
